|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
66,921,000 |
Market
Cap: |
2.90(B) |
Last
Volume: |
1,212,774 |
Avg
Vol: |
1,004,919 |
52
Week Range: |
$38.26 - $88.63 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile QuidelOrtho is engaged in the development, manufacturing and marketing of diagnostic testing solutions. Co. provides diagnostic testing solutions under various brand names, including, among others, the following: Quidel®, QuickVue®, QuickVue+®, Sofia®, Triage®, Solana®, Virena®, MicroVue, Lyra®, FreshCells, D3®, FastPoint®, ReadyCells®, Super E-Mix, InflammaDry®, AdenoPlus®, ELVIRA®, ELVIS® and Thyretain®. Co.'s diagnostic testing solutions are separated into its four product categories: rapid immunoassay, cardiometabolic immunoassay, molecular diagnostic solutions and specialized diagnostic solutions.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Steward Randall J |
Chief Financial Officer |
|
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
1,335 |
18,125 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-01-29 |
4 |
S |
$55.09 |
$1,391,023 |
D/D |
(25,250) |
294,313 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2019-01-29 |
4 |
OE |
$15.28 |
$385,820 |
D/D |
25,250 |
319,563 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-01-19 |
4 |
D |
$52.99 |
$83,353 |
D/D |
(1,573) |
13,225 |
|
- |
|
Abney Michael Donald Jr. |
SVP - Distribution |
|
2019-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
6,077 |
14,798 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2019-01-04 |
4 |
OE |
$13.25 |
$191,449 |
D/D |
14,449 |
29,628 |
|
- |
|
Steward Randall J |
Chief Financial Officer |
|
2018-12-03 |
4 |
S |
$61.51 |
$922,653 |
D/D |
(15,000) |
16,790 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-11-28 |
4 |
S |
$61.17 |
$1,103,079 |
D/D |
(18,033) |
294,313 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-11-28 |
4 |
OE |
$12.36 |
$250,009 |
D/D |
18,033 |
312,346 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-10-31 |
4 |
S |
$65.10 |
$469,827 |
D/D |
(7,217) |
294,313 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-10-31 |
4 |
OE |
$12.36 |
$89,202 |
D/D |
7,217 |
301,530 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-09-28 |
4 |
S |
$65.19 |
$1,646,048 |
D/D |
(25,250) |
294,313 |
|
- |
|
Bryant Douglas C |
President & CEO |
|
2018-09-28 |
4 |
OE |
$12.36 |
$312,090 |
D/D |
25,250 |
319,563 |
|
- |
|
Buechler Kenneth F |
Director |
|
2018-09-14 |
4 |
GA |
$0.00 |
$0 |
I/I |
400 |
100 |
|
- |
|
Buechler Kenneth F |
Director |
|
2018-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
47,769 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2018-09-11 |
4 |
S |
$72.29 |
$939,732 |
D/D |
(13,000) |
8,887 |
|
- |
|
Russell Edward Keith |
S.V.P., N.A. Commercial Ops |
|
2018-09-11 |
4 |
OE |
$15.40 |
$222,410 |
D/D |
13,000 |
21,887 |
|
- |
|
Buechler Kenneth F |
Director |
|
2018-08-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
250 |
48,269 |
|
- |
|
Buechler Kenneth F |
Director |
|
2018-08-30 |
4 |
S |
$75.01 |
$375,039 |
D/D |
(5,000) |
48,519 |
|
- |
|
Buechler Kenneth F |
Director |
|
2018-08-30 |
4 |
OE |
$11.96 |
$59,800 |
D/D |
5,000 |
53,519 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2018-08-28 |
4 |
S |
$70.80 |
$166,938 |
D/D |
(2,358) |
15,179 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2018-08-27 |
4 |
S |
$70.05 |
$450,186 |
D/D |
(6,427) |
17,537 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2018-08-24 |
4 |
S |
$70.02 |
$398,330 |
D/D |
(5,689) |
23,964 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2018-08-23 |
4 |
S |
$70.01 |
$272,042 |
D/D |
(3,886) |
29,653 |
|
- |
|
Polan Mary Lake Ph D |
Director |
|
2018-08-20 |
4 |
OE |
$11.96 |
$191,384 |
D/D |
16,002 |
33,539 |
|
- |
|
1127 Records found
|
|
Page 16 of 46 |
|
|